Medifast, the parent company of OPTAVIA, announced Nicholas Johnson has been named Chief Executive Officer. Johnson has almost two decades of experience in the direct selling industry and joined Medifast as Market President of OPTAVIA USA in 2018. Since then, he held a number of senior leadership roles before being appointed President of Medifast in 2026.

Johnson will now succeed Dan Chard, who will remain actively engaged as Chairman of the Board.

“Nick has been a driving force behind our transformation into a comprehensive metabolic health company, and the board is confident that he is the right leader to guide Medifast into its next chapter,” Chard said. “Over the past several years, we have repositioned the business and advanced our coach-led model. Nick has played a central role in that progress, and I am confident in his ability to build on this momentum as CEO.”